Stay updated on Upadacitinib in RA: Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib in RA: Safety & Efficacy Clinical Trial page.

Latest updates to the Upadacitinib in RA: Safety & Efficacy Clinical Trial page
- Check7 days agoChange DetectedAdded related topic links for 'Rheumatoid arthritis' and 'MedlinePlus Genetics' on the page. This navigation/related resources change does not modify the study content.SummaryDifference0.1%

- Check14 days agoChange DetectedRheumatoid arthritis content and the related MedlinePlus Genetics topics were removed from the page. This reduces the disease context and access to related resources for visitors reviewing the BALANCE-EXTEND study.SummaryDifference0.1%

- Check21 days agoChange DetectedAn editorial note was added indicating that publications are automatically filled from PubMed and may not all be about the study. The page revision tag was updated to v3.3.2; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check28 days agoChange DetectedAdded the topic keywords 'Rheumatoid arthritis' and 'MedlinePlus Genetics' to the page to improve context and discoverability. Removed the government funding lapse notice that previously appeared on the page.SummaryDifference0.2%

- Check42 days agoChange DetectedNo significant changes were detected in the BALANCE-EXTEND study page. The content and structure appear the same across screenshots.SummaryDifference0.2%

- Check64 days agoChange DetectedRemoved a MedlinePlus Genetics topic on Rheumatoid arthritis from the page.SummaryDifference0.1%

Stay in the know with updates to Upadacitinib in RA: Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib in RA: Safety & Efficacy Clinical Trial page.